SAFETY AND PHARMACOKINETICS OF A NOVEL HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST THE E2 GLYCOPROTEIN OF HEPATITS C VIRUS (MBL-HCV1) IN HEALTHY VOLUNTEERS

被引：2
|
作者：
Leav, B. A. [1 ]
Sloan, S. [1 ]
Blair, B. M. [1 ]
Cheslock, P. [1 ]
Knauber, M. [1 ]
Ambrosino, D. M. [1 ]
Molrine, D. C. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Boston, MA 02125 USA
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60283-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics and safety of roledumab, a novel human recombinant monoclonal anti-RhD antibody with an optimized Fc for improved engagement of FC?RIII, in healthy volunteers
    Yver, A.
    Homery, M. -C.
    Fuseau, E.
    Guemas, E.
    Dhainaut, F.
    Quagliaroli, D.
    Beliard, R.
    Prost, J. -F.
    VOX SANGUINIS, 2012, 103 (03) : 213 - 222
  • [32] Structural Basis for Penetration of the Glycan Shield of Hepatitis C Virus E2 Glycoprotein by a Broadly Neutralizing Human Antibody
    Li, Yili
    Pierce, Brian G.
    Wang, Qian
    Keck, Zhen-Yong
    Fuerst, Thomas R.
    Foung, Steven K. H.
    Mariuzza, Roy A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (16) : 10117 - 10125
  • [33] Selection of aphage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81
    Cao, J.
    Liao, X. L.
    Wu, S. M.
    Zhao, P.
    Zhao, L. J.
    Wu, W. B.
    Qi, Z. T.
    JOURNAL OF MICROBIOLOGICAL METHODS, 2007, 68 (03) : 601 - 604
  • [34] Phase I Study Evaluating the Safety and Pharmacokinetics of MDX-1303, a Fully Human Monoclonal Antibody against Bacillus anthracis Protective Antigen, in Healthy Volunteers
    Riddle, Valerie
    Leese, Phillip
    Blanset, Diann
    Adamcio, Melany
    Meldorf, Matthew
    Lowy, Israel
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (12) : 2136 - 2142
  • [35] Structural elucidation of critical residues involved in binding of human monoclonal antibodies to hepatitis C virus E2 envelope glycoprotein
    Iacob, Roxana E.
    Keck, Zhenyong
    Olson, Oakley
    Foung, Steven K. H.
    Tomer, Kenneth B.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (03): : 530 - 542
  • [36] Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody
    Cocquerel, L
    Quinn, ER
    Flint, M
    Hadlock, KG
    Foung, SKH
    Levy, S
    JOURNAL OF VIROLOGY, 2003, 77 (02) : 1604 - 1609
  • [37] A Phase 1 Study in Healthy Subjects to Evaluate the Safety and Pharmacokinetics of a Human Monoclonal Antibody (S315) Against Diphtheria Toxin
    Sullivan-Bolyai, John Z.
    Allen, Larry B.
    Cannon, Rebecca
    Cohane, Kenya P.
    Dunzo, Elise
    Goldwater, Ronald
    StCyr, Kathleen
    Wang, Yang
    Klempner, Mark S.
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [38] Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein
    Keck, Zhenyong
    Wang, Wenyan
    Wang, Yong
    Lau, Patrick
    Carlsen, Thomas H. R.
    Prentoe, Jannick
    Xia, Jinming
    Patel, Arvind H.
    Bukh, Jens
    Foung, Steven K. H.
    JOURNAL OF VIROLOGY, 2013, 87 (01) : 37 - 51
  • [39] Expression of glycoprotein hepatitis C virus in mammalian cell and application of Purified proton for detection of antibody against E2 in hepatitis C patients
    朱朝敏
    吴朝栋
    陶其敏
    冯百芳
    常锦红
    中华肝脏病杂志, 1999, (04) : 214 - 216
  • [40] Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
    He, Jinjie
    Du, Weijuan
    Yang, Haijing
    Wang, Jingjing
    Cai, Chenghang
    Ma, Qingyang
    Li, Nanyang
    Yu, Jicheng
    Wu, Xiaojie
    Wu, Jufang
    Chen, Yuancheng
    Cao, Guoying
    Zhang, Jing
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (07) : 669 - 675
12345